November 14, 2011 - Timothy Gardner (past-president of the American Heart Association) and Frank Sellke (Chairman of the Council on Cardiovascular Surgery and Anesthesia of the American Heart Association) review Cytograft’s first in human clinical results HERE.
July 15, 2011 - Cytograft highlighted in cover story in Medical Device Daily, found HERE.
June 27, 2011 - Dr. McAllister presents Cytograft's allogeneic vascular graft at the American Heart Association's prestigious Emerging Science series. The presentation can be found HERE.
June 20, 2011 - Cytograft publishes an article in Endovascular Today
December 8, 2010 - Dr. Nicolas L'Heureux, Cytograft's Chief Scientific Officer, opens and chairs the session Tissue Engineering and Regenerative Medicine in the Clinic at the North American meeting of TERMIS in Orlando, Florida.
November 22, 2010 - Dr. L'Heureux, co-founder and CSO of Cytograft, is featured in the "Industry Spotlight" of the Biomedical Engineering Society.
ABOUT US

Our Company

Cytograft is an established leader in the field of Cardiovascular Regenerative Medicine. Using cells harvested from the patient or another human donor, we are able to repair diseased cardiovascular tissues and organs.

Vision Statement

Cytograft's vision is to revolutionize cardiovascular medicine by developing cell-based therapies to repair and rebuild diseased tissues and organs without using synthetic biomaterials.

Mission Statement

Cytograft's mission is to dramatically improve cardiovascular medicine by bringing clinically useful and cost effective cell-based therapies to patients.